Dr Thaddeus C George, DVS Sciences, Sunnyvale, CA, US.
Mass cytometry uniquely resolves more than 30 probes simultaneously on a per-cell basis at high acquisition rates, thereby providing researchers with an unparalleled ability to phenotypically and functionally profile cell populations from normal and diseased states. We will describe the basic principles and workflow of the technology, and using data from published reports we will discuss the scientific questions that can be addressed with mass cytometry, the analysis methods used to explore the high-content data that is generated, and the unique insights and discoveries gained by utilizing this technology.
DVS manufactures, markets, and sells the CyTOF Mass Cytometer and mass cytometry reagents. Dr Thaddeus George leads a team of five applications scientists in a department dedicated to creating and supporting the research, pharmaceutical and clinical market for the CyTOF Mass Cytometry platform.